Our Founding Story
Corporis Medical was founded in 2015 by Dr. Alexander Veenhof, a distinguished surgeon currently practicing at the Antoni van Leeuwenhoek hospital in Amsterdam. As the Chief Executive Officer (CEO) of our company, Dr. Veenhof leverages his extensive experience in the operating room to drive innovation in minimally invasive surgery.
Inspired by his hands-on insights and through valuable collaborations with key opinion leaders such as Prof. Dr. Nicole Bouvy, Dr. Veenhof guided the establishment of our headquarters at the Maastricht Brightlands Health Campus. This strategic location enables us to benefit from close partnerships with other start-ups and access to the facilities at MUMC+, providing significant advantages in our research and development efforts.
At Corporis Medical, our expert engineering team transforms Dr. Veenhof’s product concepts into advanced medical devices. We manage the entire product lifecycle, from initial prototype development and pre-clinical studies to clinical trials and final commercialization.
Our mission is to minimize post-operative complications by advancing surgical tools with smarter, more effective technologies.
At Corporis Medical, our skilled and dedicated team has propelled us to significant achievements and milestones, including:
-
Successful Pre-Clinical Investigations for Laprixa: The Laprixa System has met all user requirements, validating its design and functionality.
-
First-in-Human Study for Mediclose: Demonstrated safe and effective closure of fascia incisions following laparoscopic surgery.
-
US Market Entry: Achieved through a 510(k) pre-market submission for the Mediclose System.
-
Investment round: closure series B 2023
-
Funding: the Laprixa product received European funding via OP-Zuid
These milestones reflect our commitment to innovation and excellence in the medical device industry.
Achievements and milestones
We aspire to revolutionize minimally invasive procedures by developing innovative solutions that enhance access, closure, and healing of surgical wounds.
Join Us as an Investor
At Corporis Medical, we are at the forefront of innovation in the minimally invasive surgery sector, driven by our commitment to advancing cutting-edge solutions, such as the Laprixa System and the Mediclose System. We invite visionary investors to partner with us in our mission to revolutionize the field of post-surgical wound healing solutions. Together, we can achieve extraordinary milestones and make a lasting impact.
If you are interested in exploring investment opportunities and becoming part of our dynamic future, please reach out to us via info@corporis-medical.com.
At Corporis Medical, we are proud to partner with visionary investors who share our commitment to advancing medical technology. Our investors play a crucial role in fueling our innovation, driving the development of groundbreaking solutions like the Laprixa® System and Mediclose® System. Their support and expertise not only provide the financial backing needed for our projects but also contribute to our strategic growth and success. Together, we are dedicated to transforming healthcare and improving patient outcomes on a global scale.
Recent Financing Round: Series B Success
In our most recent Series B financing round, we successfully raised €4 million. This all-equity round also included the conversion of existing convertible loans. Led by Unorthodox Ventures, a venture capital firm based in Austin, Texas, the round saw participation from our existing investors, Brightlands Venture Partners and LIOF.
The funds will be used to support a Randomized Controlled Trial for Mediclose and to achieve clinical validation for the fully integrated Laprixa System. This investment marks a significant milestone in our journey to advance innovative medical technologies and enhance patient outcomes.
Investors
Meet Our Investors:
Partners in Progress
